Klotho Neurosciences, Inc. (KLTO)

NASDAQ: KLTO · Real-Time Price · USD

0.4917

+0.0407 (9.02%)

At close: Oct 3, 2025, 4:00 PM EDT

0.4900

-0.0017 (-0.35%)

After-hours: Oct 3, 2025, 7:57 PM EDT

Klotho Neurosciences Employees

Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.

Employees

3

Change

2

Growth

200.00%

Revenue / Employee

n/a

Profits / Employee

-$3,784,634

Market Cap

30.18M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	3	2	200.00%
Dec 31, 2022	1	-2	-66.67%
Dec 31, 2021	3	2	200.00%
Dec 31, 2011	1	0	-
Dec 31, 2010	1	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

KLTO News

4 days ago - Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership - PRNewsWire
26 days ago - Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar - PRNewsWire
6 weeks ago - Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market - PRNewsWire
7 weeks ago - Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology - PRNewsWire
2 months ago - UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
2 months ago - Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
2 months ago - Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets - PRNewsWire
2 months ago - Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules - PRNewsWire